Tom Spencer

JANUARY 31, 2025

In recent years, there have been large M&A deals involving pharmaceutical and biotechnology companies, and a significant area of expansion in the technology space – health tech. The global life sciences consulting market is expected to grow by around 10% per year from 2024 to 2029. What is life sciences consulting?

Biotechnology 88

Biotechnology Healthcare Pharmaceuticals Consulting 88

Harvard Business

NOVEMBER 29, 2016

Historically, the pharmaceutical industry has recruited SAS programmers who have executed well-defined analyses of clinical trials in a standardized, efficient manner. It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing.

Data 70

Data Pharmaceuticals Biotechnology Methodologies 70

Harvard Business

JANUARY 11, 2017

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. Remaining efficient and productive overtook deeper reflection on the ethical implications of “selling” products to customers without their knowledge.

Ethics 70

Ethics Training Training Exercises 70

Harvard Business

JUNE 16, 2016

Manufacturers, on the other hand, value safety just as much as performance, so that they don’t have to add extra shielding to the battery that increases weight and diminishes overall efficiency. Draetta of IACS has found many of the same issues arise in pharmaceutical research.

Government 70

Government Research Journal Biotechnology 70

Tom Spencer

JANUARY 17, 2025

As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. If policies support research, development, and efficient approval processes, the biotech sector could thrive even amidst political turbulence.

Policies 88

Policies Healthcare Biotechnology Industry 88